After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
Starpax Biopharma is preparing to start clinical trials this year with its patented Starpax cancer treatment platform across six unmet needs, including pancreatic, breast, colorectal, head & neck, uterus and prostate cancer.
Source: benzinga.com